Bio-Techne Certifies over 1,000 Antibodies for Simple Western

MINNEAPOLIS, Minnesota [October 26, 2015] – Bio-Techne Corporation announced today that its R&D Systems®, Novus Biologicals®, and ProteinSimple® brands have collaborated to certify over 1,000 antibodies for the Simple Western™ platform. This milestone demonstrates the power of combining premier reagent providers with innovative protein analysis systems. The combination will enable scientists to easily transition to quantifying proteins with the Simple Western system from the tedious and semi-quantitative Western Blot method in use today.

“Antibody validation and reproducibility are a continuing concern in our industry.” says Birte Aggeler, Director of Antibody Development at R&D Systems. “The Simple Western platform from ProteinSimple® takes the variability out of the Western blotting process while reducing the time to results and increasing the detection sensitivity.  We embarked on a program to assay our most popular antibodies on the Simple Western platform that would provide our customers with a large number of certified reagents to choose from for their research.”

There have been many forums and articles citing the time and cost of poorly validated, poorly performing antibodies to the life science research community. Adding the antibody certification program for Simple Western gives our customers a high level of confidence in the antibodies they purchase from Bio-Techne, saves time and resources in experiment optimization and allows customers to dedicate more time to data analysis. This is an on-going effort that we take very seriously. It shows our dedication to being a responsible and reliable reagent manufacturer. The Simple Western certification project is part of a continuous effort in providing more validation data on our antibodies.

In addition to the Simple Western validation data, the certified antibodies are cited in over 200 customer reviews, 6,600 citations in peer reviewed publications, and data from more than 3,000 application validations including Flow Cytometry, Immunocytochemistry, and Immunohistochemistry.

More information about the Simple Western certified antibodies and Simple Western is available at


About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $452 million in net sales in fiscal 2015 and has approximately 1,500 employees worldwide. For more information on Bio-Techne and its brands, please visit


About R&D Systems
R&D Systems, a Bio-Techne brand, has been serving the research community for over 35 years with quality reagents that enable life science research. It established itself by being one of the first companies to make cytokines commercially available in the late 1970s. Its product portfolio has expanded to become a world leader in immunoassays as well as a producer of antibodies, arrays, stem cell products, cell selection and other cell biology tools. For more information, visit


About ProteinSimple
ProteinSimple, a Bio-Techne brand, helps researchers gain a better understanding of proteins and their role in disease. ProteinSimple develops and commercializes proprietary systems and consumables for protein analysis that ultimately help reveal new insights into the true nature of proteins. The goal is to make protein analysis simpler, more quantitative and affordable. Its comprehensive portfolio of tools includes Simple Western systems that quantify protein expression and Biologics systems that probe the structure and purity of protein-based therapeutics. For more information, visit


About Novus Biologicals
Novus Biologicals, a Bio-Techne brand, accelerates scientific discovery by developing and marketing unique products in the forefront of science. Novus Biologicals provides primary antibodies, secondary antibodies, conjugated antibodies and proteins to the bioscience community. All of its products are 100% guaranteed to conform to the application claims listed on the datasheet. Novus Biologicals is committed to innovation and has formed and will continue to form ongoing partnerships with leading researchers. For more information visit


Karen Padgett
Vice President, Global Marketing
612- 379- 2956

Release Date: 
Tuesday, November 3, 2015 - 08:15